A software to facilitates data analysis and software integration. CCPN provides tools and knowledge to maximise the impact of the biological nuclear magnetic resonance (NMR) studies. This software includes tool for processing and analysis of NMR data, for calculation and validation of structures and for subsequent deposition of data in the public archives. CCPN is a fully generic data modelling framework that could be used in any area of knowledge.

User report

Vote up tools and offer feedback
Give value to tools and make your expertise visible

0 user reviews

0 user reviews

No review has been posted.

CCPN forum

Communicate with other users
Participate in the forum to get support for using tools. Ask questions about technical specifications.

No open topic.

CCPN versioning

Upload and version your source code
Get your DOI for better tool traceability. Archive your releases so the community can easily visualize progress on you work.

No versioning.

CCPN classification

CCPN specifications

Software type:
Restrictions to use:
Programming languages:
C, C++, Java, Python
Computer skills:
Source code URL:
Command line interface
Operating system:
Unix/Linux, Mac OS, Windows
GNU General Public License version 2.0
Issue URL:

CCPN support



Promote your skills
Define all the tasks you managed and assign your profile the appropriate badges. Become an active member.



Department of Biochemistry, University of Cambridge, Cambridge, UK; MSD group, EMBL-EBI, European Bioinformatics Institute, Wellcome Trust Genome Campus Hinxton, Cambridge, UK; Biotechnology Division, Gaithersburg, MD, USA; Department of Chemistry and Chemical Biology, Rutgers University, Rutgers, The State University of New Jersey, NJ, USA

Funding source(s)

This work was supported by the CCPN project, the EU ‘Quality of Life and Management of Living Resources’ program (grants n°QLRI-CT-2001-00015 and QLK2- CT-2000-01313), the Astra-Zeneca, Genentech, Dupont Pharma and GlaxoSmithKline.

Link to literature

By using OMICtools you acknowledge that you have read and accepted the terms of the end user license agreement.